PEAK6 Investments’s Quest Diagnostics DGX Stock Holding History

PEAK6 Investments’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,875	Closed	-$429K	–	3596
2024 Q2	$394K	Buy	2,875 +901	+46%	+$123K	﹤0.01%	2382
2024 Q1	$263K	Buy	+1,974	New	+$256K	﹤0.01%	2886
2022 Q4	–	Sell	-20,358	Closed	-$2.93M	–	4593
2022 Q3	$2.5M	Buy	20,358 +19,659	+2,812%	+$2.59M	0.01%	1362
2022 Q2	$93K	Sell	699 -748	-52%	-$102K	﹤0.01%	5286
2022 Q1	$198K	Buy	+1,447	New	+$202K	﹤0.01%	3890
2021 Q3	–	Sell	-2,075	Closed	-$304K	–	5274
2021 Q2	$274K	Buy	2,075 +1,218	+142%	+$159K	﹤0.01%	3757
2021 Q1	$110K	Buy	+857	New	+$106K	﹤0.01%	4235
2019 Q2	–	Sell	-12,243	Closed	-$1.18M	–	3782
2019 Q1	$1.1M	Buy	+12,243	New	+$1.06M	0.01%	1767
2018 Q4	–	Sell	-995	Closed	-$107K	–	4156
2018 Q3	$107K	Buy	+995	New	+$109K	﹤0.01%	3508

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return

PEAK6 Investments's DGX Position: Q3 2024 in Review

PEAK6 Investments sold out of Quest Diagnostics (DGX) in Q3 2024, closing a stake of 2,875 shares — an estimated $429K sold.

PEAK6 Investments first reported a position in DGX in Q3 2018 and held it in 9 quarters. The position peaked at $2.5M in Q3 2022. 846 funds tracked by Wall St. Rank hold DGX as of Q3 2024.

PEAK6 Investments reported no remaining Quest Diagnostics position as of Q3 2024 after selling out during the quarter.
PEAK6 Investments sold 2,875 Quest Diagnostics shares in Q3 2024, an estimated $429K.
PEAK6 Investments first reported a position in Quest Diagnostics in Q3 2018 and held it in 9 quarters.
PEAK6 Investments's Quest Diagnostics position peaked at $2.5M in Q3 2022.
846 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.